Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pleiotropic Effects of GLP-1 and Analogs on Cell Signaling, Metabolism, and Function
Jordan Rowlands, Julian Ik‐Tsen Heng, Philip Newsholme, et al.
Frontiers in Endocrinology (2018) Vol. 9
Open Access | Times Cited: 235

Showing 1-25 of 235 citing articles:

The brain as an insulin-sensitive metabolic organ
Joshua L. Milstein, Heather A. Ferris
Molecular Metabolism (2021) Vol. 52, pp. 101234-101234
Open Access | Times Cited: 147
The anti-inflammatory and immunological properties of GLP-1 Receptor Agonists
Giulia Bendotti, Laura Montefusco, Maria Elena Lunati, et al.
Pharmacological Research (2022) Vol. 182, pp. 106320-106320
Closed Access | Times Cited: 147
Regulation of Postabsorptive and Postprandial Glucose Metabolism by Insulin-Dependent and Insulin-Independent Mechanisms: An Integrative Approach
George Dimitriadis, Eirini Maratou, Aikaterini Kountouri, et al.
Nutrients (2021) Vol. 13, Iss. 1, pp. 159-159
Open Access | Times Cited: 134
Anti-diabetic drugs and weight loss in patients with type 2 diabetes
Elisa Lazzaroni, Moufida Ben Nasr, Cristian Loretelli, et al.
Pharmacological Research (2021) Vol. 171, pp. 105782-105782
Open Access | Times Cited: 121
Effects of Diet, Lifestyle, Chrononutrition and Alternative Dietary Interventions on Postprandial Glycemia and Insulin Resistance
Emilia Papakonstantinou, Oikonomou Christina, George‐John E. Nychas, et al.
Nutrients (2022) Vol. 14, Iss. 4, pp. 823-823
Open Access | Times Cited: 114
Glucagon-like peptide-1 (GLP-1) receptor agonists and neuroinflammation: Implications for neurodegenerative disease treatment
Katherine O. Kopp, Elliot J. Glotfelty, Yazhou Li, et al.
Pharmacological Research (2022) Vol. 186, pp. 106550-106550
Open Access | Times Cited: 114
Current and future therapies for type 1 diabetes
Bernt Johan von Scholten, Frederik Flindt Kreiner, Stephen Gough, et al.
Diabetologia (2021) Vol. 64, Iss. 5, pp. 1037-1048
Open Access | Times Cited: 104
Hypoxia-induced signaling in the cardiovascular system: pathogenesis and therapeutic targets
Yongchao Zhao, Weidong Xiong, Chaofu Li, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 95
Glucagon-like peptide-1 receptor: mechanisms and advances in therapy
Zhikai Zheng, Zong Yao, Yiyang Ma, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 73
Anti-inflammatory role of glucagon-like peptide 1 receptor agonists and its clinical implications
Saleh Hadi Alharbi
Therapeutic Advances in Endocrinology and Metabolism (2024) Vol. 15
Open Access | Times Cited: 62
Glucagon-Like Peptide-1: New Regulator in Lipid Metabolism
Tong Bu, Ziyan Sun, Yi Pan, et al.
Diabetes & Metabolism Journal (2024) Vol. 48, Iss. 3, pp. 354-372
Open Access | Times Cited: 22
The individual response to antibiotics and diet — insights into gut microbial resilience and host metabolism
Lars M. M. Vliex, John Penders, Arjen Nauta, et al.
Nature Reviews Endocrinology (2024) Vol. 20, Iss. 7, pp. 387-398
Closed Access | Times Cited: 17
GLP-1 Receptor Agonists and Kidney Protection
Eulalia Greco, Giuseppina Russo, Annalisa Giandalia, et al.
Medicina (2019) Vol. 55, Iss. 6, pp. 233-233
Open Access | Times Cited: 129
Targeted pharmacological therapy restores β-cell function for diabetes remission
Stephan Sachs, Aimée Bastidas-Ponce, Sophie Tritschler, et al.
Nature Metabolism (2020) Vol. 2, Iss. 2, pp. 192-209
Open Access | Times Cited: 127
GLP-1: Molecular mechanisms and outcomes of a complex signaling system
Nicholas K. Smith, Troy A. Hackett, Aurelio Galli, et al.
Neurochemistry International (2019) Vol. 128, pp. 94-105
Open Access | Times Cited: 113
Protection against Alzheimer's disease by luteolin: Role of brain glucose regulation, anti‐inflammatory activity, and the gut microbiota‐liver‐brain axis
James W. Daily, Suna Kang, Sunmin Park
BioFactors (2020) Vol. 47, Iss. 2, pp. 218-231
Closed Access | Times Cited: 110
Glucagon-Like Peptide 1 Receptor Agonists and Heart Failure
Muhammad Shahzeb Khan, Gregg C. Fonarow, Darren K. McGuire, et al.
Circulation (2020) Vol. 142, Iss. 12, pp. 1205-1218
Open Access | Times Cited: 99
Autonomic nervous system activity changes in patients with hypertension and overweight: role and therapeutic implications
P. Valensi
Cardiovascular Diabetology (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 91
Butyrate generated by gut microbiota and its therapeutic role in metabolic syndrome
Stephanie Bridgeman, Wendy Northrop, Phillip E. Melton, et al.
Pharmacological Research (2020) Vol. 160, pp. 105174-105174
Closed Access | Times Cited: 88
Current perspectives of oleic acid: Regulation of molecular pathways in mitochondrial and endothelial functioning against insulin resistance and diabetes
Kanwal Rehman, Kamran Haider, Komal Jabeen, et al.
Reviews in Endocrine and Metabolic Disorders (2020) Vol. 21, Iss. 4, pp. 631-643
Closed Access | Times Cited: 79
The mechanism and efficacy of GLP-1 receptor agonists in the treatment of Alzheimer’s disease
Haiyang Du, Xiaoyu Meng, Yao Yu, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 48
GLP-1 regulates exercise endurance and skeletal muscle remodeling via GLP-1R/AMPK pathway
Luting Wu, Min Zhou, Tianyou Li, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2022) Vol. 1869, Iss. 9, pp. 119300-119300
Open Access | Times Cited: 44
Anti-Inflammatory Effects of GLP-1 Receptor Activation in the Brain in Neurodegenerative Diseases
Yolanda Diz-Chaves, Zainab Mastoor, Carlos Spuch, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 9583-9583
Open Access | Times Cited: 41
Obesity and Type 2 Diabetes: Adiposopathy as a Triggering Factor and Therapeutic Options
Angelica Artasensi, Angelica Mazzolari, Alessandro Pedretti, et al.
Molecules (2023) Vol. 28, Iss. 7, pp. 3094-3094
Open Access | Times Cited: 36
Exploring the Complex Relationship between Diabetes and Cardiovascular Complications: Understanding Diabetic Cardiomyopathy and Promising Therapies
Nilanjan Ghosh, Leena Chacko, Hiranmoy Bhattacharya, et al.
Biomedicines (2023) Vol. 11, Iss. 4, pp. 1126-1126
Open Access | Times Cited: 29
Page 1 - Next Page

Scroll to top